drugset
drugset / Trial / NCT00944307

Effect of Antacids on the Pharmacokinetics of Raltegravir

NCT00944307 ↗

Phase 1 Completed 17 enrolled University of Colorado, Denver
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to test whether there is a drug interaction between raltegravir (a medicine used to treat the human immunodeficiency virus or HIV) and antacids.

Timeline

Start
2009-07
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Raltegravir Other / unclassified 400 mg Oral

Indications

HIV infectious disease